Efficacy of tight control strategy in the treatment of adult-onset Still disease.

Efficacy of tight control strategy in the treatment of adult-onset Still disease


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: آیدا مالک مهدوی , افشین خلیلی , مهرزاد حاج علیلوی بناب , علیرضا خبازی اسکویی , ثمین علی حسینی , مهران جابری نژاد

کلمات کلیدی: Adult-onset Still’s disease · Remission · Tight control strategy · Treat to target strategy · Treatment

نشریه: 55104 , 10 , 40 , 2021

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله علیرضا خبازی اسکویی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه بیماری های بافت همبند
کد مقاله 76789
عنوان فارسی مقاله Efficacy of tight control strategy in the treatment of adult-onset Still disease.
عنوان لاتین مقاله Efficacy of tight control strategy in the treatment of adult-onset Still disease
ناشر 8
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Background Adult-onset Still’s disease (AOSD) characterized by a high spiking fever, skin rash, arthritis, and leukocytosis. The aim of the present study was considering the long-term outcomes of patients with AOSD who were treated with tight control strategy with disease modifying anti-rheumatic drugs (DMARDs). Methods Fifty-six patients with AOSD treated with tight control strategy were included. Four levels of remission were defined. Remission on-treatment was defined as the clinical remission, patient global assessment (PGA) ≤ 1, and prednisolone dose ≤ 5 mg/day for at least 6 months. Remission off-treatment was defined as the clinical remission and PGA≤ 1 for at least 6 months as well as discontinuation of prednisolone, DMARDs, and biologics. Sustained remission on-treatment was defined as the clinical remission, PGA ≤1, and prednisolone dose ≤5 mg/day for≥5 years. Sustained remission off-treatment was defined as the clinical remission and PGA ≤ 1 for ≥ 5 years as well as discontinuation of prednisolone, DMARDs, and biologics. Results Throughout a median follow-up of 47 months, remission on-treatment and off-treatment were obtained in 94.6% and 44.6% of patients, respectively. Sustained remission on-treatment and off-treatment were obtained in 79.2 and 8.3% of patients, respectively. Glucocorticoids (GCs) and DMARDs were discontinued in 66.1% and 48.2% of the patients, respectively. Apart from the older age of the patients in the on-GCs group, no significant differences were observed between the groups. Conclusion Our study showed that using DMARDs with tight control strategy at the presentation of AOSD may control disease activity successfully

نویسندگان
hide/show

نویسنده نفر چندم مقاله
آیدا مالک مهدویاول
افشین خلیلیدوم
مهرزاد حاج علیلوی بنابششم
علیرضا خبازی اسکوییهشتم
ثمین علی حسینیسوم
مهران جابری نژادچهارم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
MalekMahdavi2021_Article_EfficacyOfTightControlStrategy.pdf1400/07/06798443دانلود